NEUREN PHARMACEUTICALS LIMITED revenue for the last year amounted to 227.80 M AUD, the most of which — 213.24 M AUD — came from its highest performing source at the moment, Commercial Products, the year earlier bringing 231.93 M AUD. The greatest contribution to the revenue figure was made by United States — last year it brought NEUREN PHARMACEUTICALS LIMITED 213.24 M AUD, and the year before that — 231.93 M AUD.